Skip to NavigationSkip to content

Pharmafile - Research and Development

Sage Therapeutics' depression drug falls short at Phase 3
Sage Therapeutics has announced that its candidate SAGE-217 flopped in Phase 3 trials investigating its efficacy in symptom reduction for major...
Top Ten most popular articles on Pharmafile.com this week
Widespread bribery in India’s pharma industry, Purdue Pharma President ignored addiction concerns with OxyContin, and Lynparza scores NICE...
Partnership with payers: Communicating and negotiating with impact
NDA's Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising...
FDA-approved drug can repair gut leakiness in types of bowel disease
A team of biomedical scientists at the University of California has found that a FDA-approved drug for treating rheumatoid arthritis and ulcerative...
>> More Research and Development News Stories

Features

Patient experience: Living with desmoid fibromatosis

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis and experience with the UK...

>> More Features

Appointments

Dr Richard Torbett is named as the new Chief Executive of the ABPI

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will assume the...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches